CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, was ...

The global preclinical medical device testing services market is on the verge of substantial expansion, projected to soar from USD 2.8 billion in 2022 to an impressive USD 6.63 billion by 2032. This ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

While most cancer happens by chance, about 5-10% of cases are hereditary. Hereditary cancers are caused by a harmful variant ...

The chemotherapy drugs 5-FU and capecitabine could harm or kill you if you have a variant in the DPYD gene. Request genetic testing before you take these drugs.

Adam Brufsky, MD, PhD, professor of medicine at the University of Pittsburgh School of Medicine; Megan Kruse, MD, breast medical oncologist at Cleveland Clinic; and Ruta Rao, MD, professor of medicine ...

In the video, Heliospect Genomics sells its services to customers ... service raises moral and medical questions. Duggan Wells, professor of reproductive genetics at the University of Oxford ...

Facebook’s business model revolves around sharing information with many third parties. Unlike medical providers, genetic ...

When doctors and other types of providers provide pretest genetic testing education to patients, it allows Clearview's ...